天弘恒生沪深港创新药精选50ETF发起联接C(014565)资产负债表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
资产 |
银行存款 |
- |
- |
- |
2,817,535.34 |
结算备付金 |
37,904.02 |
26,876.77 |
217,846.28 |
2,860.78 |
存出保证金 |
13,329.81 |
20,546.58 |
41,516.30 |
45,987.35 |
交易性金融资产 |
62,540,492.79 |
57,714,553.17 |
82,988,916.92 |
44,318,104.05 |
其中:股票投资 |
1,360,990.30 |
1,859,431.01 |
2,442,388.22 |
1,769,290.01 |
债券投资 |
101,263.40 |
407,276.16 |
101,523.36 |
101,109.64 |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
442,642.41 |
568,987.95 |
- |
160,250.70 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
- |
- |
应收申购款 |
119,271.60 |
310,699.21 |
1,272,364.86 |
503,038.35 |
其他资产 |
- |
- |
- |
- |
资产总计 |
66,577,717.99 |
61,897,136.46 |
89,032,046.50 |
47,847,776.57 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
0.24 |
0.11 |
384,452.98 |
584,429.38 |
应付赎回款 |
670,027.81 |
1,447,112.46 |
1,217,938.00 |
581,401.16 |
应付管理人报酬 |
1,759.47 |
2,225.77 |
2,729.45 |
1,533.53 |
应付托管费 |
351.89 |
445.17 |
545.88 |
306.71 |
应付销售服务费 |
9,166.04 |
9,219.96 |
12,745.10 |
6,090.10 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
121,470.15 |
70,342.75 |
53,739.81 |
26,743.67 |
负债合计 |
802,775.60 |
1,529,346.22 |
1,672,151.22 |
1,200,504.55 |
所有者权益 |
实收基金 |
81,217,905.57 |
89,994,516.89 |
96,372,926.62 |
50,802,717.01 |
未分配利润 |
-15,442,963.18 |
-29,626,726.65 |
-9,013,031.34 |
-4,155,444.99 |
所有者权益合计 |
65,774,942.39 |
60,367,790.24 |
87,359,895.28 |
46,647,272.02 |
负债及所有者权益总计 |
66,577,717.99 |
61,897,136.46 |
89,032,046.50 |
47,847,776.57 |